Hadfield S T, Abbott P J, Coombs M M, Drake A F
Carcinogenesis. 1984 Nov;5(11):1395-9. doi: 10.1093/carcin/5.11.1395.
The in vitro metabolism of 15,16-dihydrocyclopenta[a]phenanthren-17-one and its 11- and 12-methyl derivatives has been compared. All three compounds form trans-3,4-dihydrodiols having quasi-diequatorial conformations and 3R,4R configurations. The trans-3,4-dihydrodiol of the mutagenic, but non-tumorigenic 15,16-dihydrocyclopenta[a]phenanthren-17-one appears to undergo stereospecific epoxidation to a syn-diol epoxide. By contrast the 3,4-dihydrodiol of the nontumorigenic 15,16-dihydro-12-methylcyclopenta[a]phenanthren-17-one appears to undergo stereospecific epoxidation to an anti diol-epoxide equivalent to that generated from 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one which is a strong carcinogen. These results are discussed with reference to the biological activities of the parent compounds.
对15,16 - 二氢环戊[a]菲 - 17 - 酮及其11 - 甲基和12 - 甲基衍生物的体外代谢进行了比较。这三种化合物均形成具有准双平伏键构象和3R,4R构型的反式 - 3,4 - 二氢二醇。具有致突变性但无致瘤性的15,16 - 二氢环戊[a]菲 - 17 - 酮的反式 - 3,4 - 二氢二醇似乎经历立体特异性环氧化生成顺式二醇环氧化物。相比之下,无致瘤性的15,16 - 二氢 - 12 - 甲基环戊[a]菲 - 17 - 酮的3,4 - 二氢二醇似乎经历立体特异性环氧化生成一种反式二醇环氧化物,该反式二醇环氧化物与由强致癌物15,16 - 二氢 - 11 - 甲基环戊[a]菲 - 17 - 酮生成的反式二醇环氧化物相当。结合母体化合物的生物活性对这些结果进行了讨论。